SCHEMBL28825544

SCHEMBL28825544

Cc1c(F)cc(-c2ccn(Cc3cncc(F)c3)n2)cc1F

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GRIN1 Q05586 17/20 0.41
GRIN2B Q13224 17/20 0.41
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28949596 0.90 GRIN1 (0.42) MAPTSMN1; SMN2GRIN1GRIN2BKDM4E
SCHEMBL28825507 0.88 SMN1; SMN2 (0.45) MAPTSMN1; SMN2GRIN1GRIN2BNPC1
SCHEMBL28825447 0.86 GRIN2B (0.50) MAPTSMN1; SMN2GRIN1GRIN2BKDM4E
SCHEMBL28825585 0.82 KDM4E (0.46) MAPTSMN1; SMN2GRIN1GRIN2BKDM4E
SCHEMBL28825494 0.81 GRIN2B (0.46) MAPTSMN1; SMN2GRIN1GRIN2BALDH1A1
SCHEMBL28931687 0.81 GRIN2B (0.48) MAPTSMN1; SMN2GRIN1GRIN2BKDM4E
SCHEMBL28825456 0.81 MAPT (0.56) MAPTSMN1; SMN2GRIN1GRIN2BKDM4E
SCHEMBL28825694 0.80 GRIN1 (0.42) MAPTSMN1; SMN2GRIN1GRIN2BKDM4E
SCHEMBL28949591 0.79 ALDH1A1 (0.44) MAPTSMN1; SMN2GRIN1GRIN2BKDM4E
SCHEMBL28825651 0.79 GRIN1 (0.52) MAPTSMN1; SMN2GRIN1GRIN2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114007610-A Substituted heteroaromatic pyrazolopyridines and their use as modulators of the GLUN2B receptor 詹森药业有限公司 2022-02-01 CN claimed
CN-114007610-A Substituted heteroaromatic pyrazolopyridines and their use as modulators of the GLUN2B receptor 詹森药业有限公司 2022-02-01 CN disclosed